STRATA Skin Sciences Inc (SSKN)
Outlook Therapeutics Inc. (OTLK)
Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS)
Coherus BioSciences Inc (CHRS)
Coherus Oncology to Participate in Upcoming Investor Conferences
DarioHealth Corp (DRIO)
DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market
Fortress Biotech Inc. (FBIOP)
Journey Medical Corporation to Participate in September 2025 Investor Conferences
Akari Therapeutics plc (AKTX)
Akari Therapeutics to Participate in the Virtual Investor Closing Bell Series
Journey Medical Corporation (DERM)
Journey Medical Corporation to Participate in September 2025 Investor Conferences
Enveric Biosciences Inc. (ENVB)
Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference
Adial Pharmaceuticals Inc (ADIL)
Adial Pharmaceuticals Granted a 180 Calendar Day Extension by Nasdaq to Regain Compliance with the Minimum Bid Price Rule
Achieve Life Sciences Inc. (ACHV)
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
PolyPid (PYPD)
PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
Autonomix Medical Inc. (AMIX)
Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study
enGene Inc (ENGNW)
enGene Achieves Target Enrollment Milestone for LEGEND Trial Pivotal Cohort
Lexicon Pharmaceuticals Inc. (LXRX)
Lexicon Pharmaceuticals Announces Presentation of Diabetic Peripheral Neuropathic Pain Patient Insights at PAINWeek 2025